Your browser doesn't support javascript.
loading
USP8 promotes the tumorigenesis of intrahepatic cholangiocarcinoma via stabilizing OGT.
Long, Guo; Wang, Dong; Tang, Jianing; Hu, Kuan; Zhou, Ledu.
Afiliación
  • Long G; Department of Liver Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Wang D; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Tang J; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
  • Hu K; Department of Liver Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Zhou L; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Cancer Cell Int ; 24(1): 238, 2024 Jul 07.
Article en En | MEDLINE | ID: mdl-38973004
ABSTRACT
Ubiquitination was considered to be a crucial factor in intrahepatic cholangiocarcinoma (iCCA) development. Herein, we identified Ubiquitin-specific peptidase 8 (USP8) as a key regulator for promoting the tumorigenesis of iCCA cell via stabilizing OGT. USP8 was overexpressed in human tumor tissues and correlated with worse survival. Moreover, the mass spectrometry and co-immunoprecipitation analysis indicated that USP8 interacted with OGT. USP8 worked as a bona fide deubiquitylase of OGT. It stabilized OGT in a deubiquitylation activity-dependent manner. Meanwhile, DUB-IN3, the USP8 inhibitor, could also restrain the malignancy of intrahepatic cholangiocarcinoma. In addition, USP8 depletion promoted the response of iCCA to pemigatinib. In conclusion, our findings pointed to a previously undocumented catalytic role for USP8 as a deubiquitinating enzyme of OGT. The USP8-OGT axis could be a potential target for iCCA therapy.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2024 Tipo del documento: Article País de afiliación: China